Type your tag names separated by a space and hit enter

Special Dosing Considerations

Special Dosing Considerations is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or purchase a subscription.

Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drug, procedures and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and MEDLINE Journals. Explore these free sample topics:

Anesthesia Central

-- The first section of this topic is shown below --

General

For many patients the average dose range for a given drug can be toxic. The purpose of this section is to describe vulnerable patient populations for which special dosing considerations must be made to protect the patient and improve clinical outcomes.

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

Quiring, Courtney, et al. "Special Dosing Considerations." Davis's Drug Guide, 16th ed., F.A. Davis Company, 2019. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations.
Quiring C, Sanoski CA, Vallerand AH. Special Dosing Considerations. Davis's Drug Guide. 16th ed. F.A. Davis Company; 2019. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations. Accessed March 24, 2019.
Quiring, C., Sanoski, C. A., & Vallerand, A. H. (2019). Special Dosing Considerations. In Davis's Drug Guide. Available from https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations
Quiring C, Sanoski CA, Vallerand AH. Special Dosing Considerations [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2019. [cited 2019 March 24]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Special Dosing Considerations ID - 109953 A1 - Quiring,Courtney, AU - Sanoski,Cynthia A, AU - Vallerand,April Hazard, BT - Davis's Drug Guide UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations PB - F.A. Davis Company ET - 16 DB - Anesthesia Central DP - Unbound Medicine ER -